🇺🇸 FDA
Patent

US 7696151

Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents

granted A61KA61K31/00A61K31/201

Quick answer

US patent 7696151 (Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/00, A61K31/201, A61K31/426, A61K31/4439